Dr. Puard is the co-founder and CEO of MAbSilico, a company that focuses on the development of antibodies and alternative scaffolds for the antibody development market. He has been working at the Luxembourg Institute of Health since 2018, where he has been involved in building a protein chip platform and identifying protein biomarkers for various types of cancer.